Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongjun Fang

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
Cancer Cell International|January 4, 2026
Low frequency and rare coding variants affect susceptibility and progression of childhood acute lymphoblastic leukemiaXiao Liu, Ru Zhang, Heng Zhang, et al.
Molecular Genetics and Metabolism Reports|June 15, 2026
A 53-week, open-label phase IIIb study of velaglucerase alfa in Chinese patients with type 1 Gaucher disease: Safety, efficacy, and pharmacokineticsLihui Zhang, Xue-Qun Luo, Yongjun Fang, et al.
Plant Molecular Biology|February 22, 2012
High-throughput sequencing-based gene profiling on multi-staged fruit development of date palm (Phoenix dactylifera, L.)Yuxin Yin, Xiaowei Zhang, Yongjun Fang, et al.
Leukemia & Lymphoma|September 19, 2015
Pri-miR-34b/c rs4938723 polymorphism contributes to acute lymphoblastic leukemia susceptibility in Chinese childrenNa Tong, Haiyan Chu, Meilin Wang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|December 27, 2011
A pangenomic study of Bacillus thuringiensisYongjun Fang, Zhaolong Li, Jiucheng Liu, et al.
Journal of Ethnopharmacology|December 20, 2025
The efficacy and safety of Huaiqihuang Granule in the treatment of childhood chronic primary immune thrombocytopenia: a multi-centre, randomized, double-blind, placebo-controlled clinical study ()Juan Han, Qiang Fu, Changda Liang, et al.
Hepatology International|April 15, 2024
PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational studyHongxiang Gao, Chenjie Xie, Jing Wang, et al.
Research and Practice in Thrombosis and Haemostasis|January 15, 2025
Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trialZhengping Li, Zekun Li, Xiaoling Cheng, et al.
Frontiers in Immunology|February 27, 2026
Efficacy of chimeric antigen receptor T-cell therapy in testicular relapse of pediatric acute lymphoblastic leukemia: a multicenter retrospective studyNing Wang, Yanjing Tang, Yong Zhuang, et al.
Science China. Life Sciences|October 25, 2025
The characteristics and prognostic analysis of therapy-related acute myeloid leukemia patients in ChinaFeifei Tang, Yunqi Wang, Yu Zhang, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Cancer Cell International|January 4, 2026
Low frequency and rare coding variants affect susceptibility and progression of childhood acute lymphoblastic leukemiaXiao Liu, Ru Zhang, Heng Zhang, et al.
Molecular Genetics and Metabolism Reports|June 15, 2026
A 53-week, open-label phase IIIb study of velaglucerase alfa in Chinese patients with type 1 Gaucher disease: Safety, efficacy, and pharmacokineticsLihui Zhang, Xue-Qun Luo, Yongjun Fang, et al.
Plant Molecular Biology|February 22, 2012
High-throughput sequencing-based gene profiling on multi-staged fruit development of date palm (Phoenix dactylifera, L.)Yuxin Yin, Xiaowei Zhang, Yongjun Fang, et al.
Leukemia & Lymphoma|September 19, 2015
Pri-miR-34b/c rs4938723 polymorphism contributes to acute lymphoblastic leukemia susceptibility in Chinese childrenNa Tong, Haiyan Chu, Meilin Wang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|December 27, 2011
A pangenomic study of Bacillus thuringiensisYongjun Fang, Zhaolong Li, Jiucheng Liu, et al.
Journal of Ethnopharmacology|December 20, 2025
The efficacy and safety of Huaiqihuang Granule in the treatment of childhood chronic primary immune thrombocytopenia: a multi-centre, randomized, double-blind, placebo-controlled clinical study ()Juan Han, Qiang Fu, Changda Liang, et al.
Hepatology International|April 15, 2024
PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational studyHongxiang Gao, Chenjie Xie, Jing Wang, et al.
Research and Practice in Thrombosis and Haemostasis|January 15, 2025
Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trialZhengping Li, Zekun Li, Xiaoling Cheng, et al.
Frontiers in Immunology|February 27, 2026
Efficacy of chimeric antigen receptor T-cell therapy in testicular relapse of pediatric acute lymphoblastic leukemia: a multicenter retrospective studyNing Wang, Yanjing Tang, Yong Zhuang, et al.
Science China. Life Sciences|October 25, 2025
The characteristics and prognostic analysis of therapy-related acute myeloid leukemia patients in ChinaFeifei Tang, Yunqi Wang, Yu Zhang, et al.
Pageof 15